Viewing data from:

CORTRIL

NDA

HYDROCORTISONE ACETATE | N009164 | PFIZER LABORATORIES DIV PFIZER INC

1 strength0 unique patents0 unique exclusivities

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

API Supply Chain4 active DMFs6 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

HENAN LIHUA PHARMACEUTICAL CO LTDHYDROCORTISONE ACETATE

DMF 296852015

SYMBIOTEC PHARMALAB PRIVATE LTDHYDROCORTISONE ACETATE USP

DMF 308202016

JIANGSU LIANHUAN PHARMACEUTICAL CO LTDHYDROCORTISONE ACETATE

DMF 361202021

SHANDONG XINHUA PHARMACEUTICAL CO LTDHYDROCORTISONE ACETATE

DMF 376532022

PASADENA RESEARCH LABORATORIES INCInactiveHYDROCORTISONE ACETATE

DMF 1171953

SANOFI CHIMIEInactiveHYDROCORTISONE ACETATE

DMF 35701979

SCHERING AGInactiveHYDROCORTISONE ACETATE

DMF 47451982

QUATRUMInactiveHYDROCORTISONE ACETATE

DMF 67861987

SHANDONG XINHUA PHARMACEUTICAL CO LTDInactiveHYDROCORTISONE ACETATE

DMF 172632004

YANGZHOU PHARMACEUTICAL CO LTDInactiveHYDROCORTISONE ACETATE

DMF 321352017

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 25MG/ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.